Glutathione S-transferase polymorphisms associated with risk of breast cancer in southern Taiwan

Breast

Volumn 15, Issue 6, 2006, Pages 754-761

  Chang, Tsai Wang ^a   Wang, Shuei Ming ^a   Guo, Yue Liang L ^a   Tsai, Pei Chien ^a   Huang, Chien Jung ^b   Huang, Wenya ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

BRCA; Breast cancer; DNA damage and repair; Glutathione s transferase; Homologous recombination

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; DNA; ESTROGEN; GLUTATHIONE TRANSFERASE; QUINONE DERIVATIVE; RAD51 PROTEIN; XENOBIOTIC AGENT;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; DNA REPAIR; ESTROGEN METABOLISM; FEMALE; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HOMOLOGOUS RECOMBINATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TAIWAN;

EID: 33751181913     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2006.03.008     Document Type: Article

References (44)

1. Chen C.J., You S.L., Lin L.H., Hsu W.L., and Yang Y.W. Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 32 (2002) S66-S81
2. Mitrunen K., and Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544 (2003) 9-41
3. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev 21 (2000) 40-54
4. Thompson P.A., and Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr 27 (2000) 125-134
5. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94 (1997) 10937-10942
6. Shen M.R., Jones I.M., and Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58 (1998) 604-608
7. Raftogianis R., Creveling C., Weinshilboum R., and Weisz J. Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 27 (2000) 113-124
8. Weisz J., Fritz-Wolz G., Gestl S., Clawson G.A., Creveling C.R., Liehr J.G., et al. Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells. Am J Pathol 156 (2000) 184-188
9. Oberley L.W., and Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res 39 (1979) 1141-1149
10. Coughlin S.S., Khoury M.J., and Steinberg K.K. BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives. Am J Prev Med 16 (1999) 91-98
11. Scully R. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res 2 (2000) 324-330
12. Welcsh P.L., and King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10 (2001) 705-713
13. Miller K. Estrogen and DNA damage: the silent source of breast cancer?. J Natl Cancer Inst 95 (2003) 100-102
14. Hughes-Davies L., Huntsman D., Ruas M., Fuks F., Bye J., Chin S.F., et al. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell 115 (2003) 523-535
15. Sambrook J., Russell D.W., and Sambrook J. Molecular cloning: a laboratory manual (2001), Cold Spring Harbor Press, Cold Spring Harbor, NY
16. Hayashi S.I., Watanabe J., Nakachi K., and Kawajiri K. PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 19 (1991) 4797
17. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., and Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263 (1990) 131-133
18. In: Pacifici G.M., and Pelkonen O. (Eds). Interindividual variability in human drug metabolism (2001), Taylor & Francis, London
19. Tenhunen J., Heikkila P., Alanko A., Heinonen E., Akkila J., and Ulmanen I. Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland. Cancer Lett 144 (1999) 75-84
20. Dunning A.M., Healey C.S., Pharoah P.D., Teare M.D., Ponder B., and Easton D.F. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8 (1999) 843-854
21. Healey C.S., Dunning A.M., Teare M.D., Chase D., Parker L., Burn J., et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26 (2000) 362-364
22. Ishitobi M., Miyoshi Y., Ando A., Hasegawa S., Egawa C., Tamaki Y., et al. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis. Clin Cancer Res 9 (2003) 1376-1380
23. Levy-Lahad E., Lahad A., Eisenberg S., Dagan E., Paperna T., Kasinetz L., et al. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98 (2001) 3232-3236
24. Beller U., Halle D., Catane R., Kaufman B., Hornreich G., and Levy-Lahad E. High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients, regardless of family history. Gynecol Oncol 67 (1997) 123-126
25. Spurdle A.B., Hopper J.L., Chen X., Dite G.S., Cui J., McCredie M.R., et al. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 11 (2002) 413-416
26. Berman D.B., Wagner-Costalas J., Schultz D.C., Lynch H.T., Daly M., and Godwin A.K. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 58 (1996) 1166-1176
27. Li S.S., Tseng H.M., Yang T.P., Liu C.H., Teng S.J., Huang H.W., et al. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104 (1999) 201-204
28. Hou M.F., Tsai K.B., Fan H.M., Wang C.Y., Lin W.C., Liu C.S., et al. Familial breast cancer in southern Taiwan. Kaohsiung J Med Sci 16 (2000) 414-421
29. Hengstler J.G., Arand M., Herrero M.E., and Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer 154 (1998) 47-85
30. Strange R.C., and Fryer A.A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC 148 (1999) 231-249
31. Friedberg E.C., Walker G.C., and Siede W. DNA repair and mutagenesis (1995), ASM Press, Washington, DC
32. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21 (2002) 8981-8993
33. Liu Y., and West S.C. Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res 4 (2001) 9-13
34. Moynahan M.E., Pierce A.J., and Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 7 (2001) 263-272
35. Willers H., Xia F., and Powell S.N. Recombinational DNA repair in cancer and normal cells: the challenge of functional analysis. J Biomed Biotechnol 2 (2002) 86-93
36. 6-methylguanine-DNA methyltransferase activity in breast and brain tumors. Int J Cancer 61 (1995) 321-326
37. Feigelson H.S., and Henderson B.E. Estrogens and breast cancer. Carcinogenesis 17 (1996) 2279-2284
38. Nandi S., Guzman R.C., and Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 92 (1995) 3650-3657
39. Zhu B.T. Conney AH, Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 (1998) 1-27
40. Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4 (2002) 197-201
41. Hsiao W.C., Young K.C., Lin S.L., and Lin P.W. Estrogen receptor-α polymorphism in a Taiwanese clinical breast cancer population: a case-control study. Breast Cancer Res 6 (2004) 180-186
42. Montano M.M., Deng H., Liu M., Sun X., and Singal R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 23 (2004) 2442-2453
43. Mobley J.A., and Brueggemeier R.W. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis 25 (2004) 3-9
44. Gold B., Kalush F., Bergeron J., Scott K., Mitra N., Wilson K., et al. Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res 64 (2004) 8891-8900